The FDA granted accelerated approval to Bristol-Myers’s skin-cancer treatment Opdivo, which uses the body’s immune system to fight tumors.
WSJ.com: Health, Wall Street Journal: Business: Health
Mon, 12/22/2014 - 7:06pm
The FDA granted accelerated approval to Bristol-Myers’s skin-cancer treatment Opdivo, which uses the body’s immune system to fight tumors.